132 related articles for article (PubMed ID: 17634560)
21. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
22. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.
Sturgis EM; Zheng R; Li L; Castillo EJ; Eicher SA; Chen M; Strom SS; Spitz MR; Wei Q
Carcinogenesis; 2000 Dec; 21(12):2219-23. PubMed ID: 11133811
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
Neumann AS; Lyons HJ; Shen H; Liu Z; Shi Q; Sturgis EM; Shete S; Spitz MR; El-Naggar A; Hong WK; Wei Q
Int J Cancer; 2005 May; 115(1):131-6. PubMed ID: 15688408
[TBL] [Abstract][Full Text] [Related]
24. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.
Gallì P; Cadoni G; Volante M; De Feo E; Amore R; Giorgio A; Arzani D; Paludetti G; Ricciardi G; Boccia S
BMC Cancer; 2009 May; 9():137. PubMed ID: 19426493
[TBL] [Abstract][Full Text] [Related]
25. Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites.
Guan X; Wang LE; Liu Z; Sturgis EM; Wei Q
J Cell Mol Med; 2013 Jul; 17(7):873-8. PubMed ID: 23742673
[TBL] [Abstract][Full Text] [Related]
26. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study.
Shen H; Zheng Y; Sturgis EM; Spitz MR; Wei Q
Cancer Lett; 2002 Sep; 183(2):123-30. PubMed ID: 12065086
[TBL] [Abstract][Full Text] [Related]
27. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Shete S; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
[TBL] [Abstract][Full Text] [Related]
28. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
Li F; Sturgis EM; Chen X; Zafereo ME; Wei Q; Li G
Cancer; 2010 May; 116(10):2350-9. PubMed ID: 20225330
[TBL] [Abstract][Full Text] [Related]
29. Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck.
Guan X; Liu Z; Wang L; Wang LE; Sturgis EM; Wei Q
Carcinogenesis; 2013 Apr; 34(4):812-7. PubMed ID: 23241165
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck.
Liu Z; Li G; Wei S; Niu J; El-Naggar AK; Sturgis EM; Wei Q
Cancer; 2010 Oct; 116(20):4753-60. PubMed ID: 20549817
[TBL] [Abstract][Full Text] [Related]
31. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH
Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
Zhang Z; Shi Q; Sturgis EM; Spitz MR; Wei Q
Pharmacogenet Genomics; 2005 Aug; 15(8):557-64. PubMed ID: 16006999
[TBL] [Abstract][Full Text] [Related]
35. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
36. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck.
Liu Z; Li G; Wei S; Niu J; Wang LE; Sturgis EM; Wei Q
Carcinogenesis; 2010 Nov; 31(11):1977-81. PubMed ID: 20802237
[TBL] [Abstract][Full Text] [Related]
37. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
38. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.
Chen K; Zhao H; Hu Z; Wang LE; Zhang W; Sturgis EM; Wei Q
Clin Cancer Res; 2008 Oct; 14(19):6343-9. PubMed ID: 18829519
[TBL] [Abstract][Full Text] [Related]
39. Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis.
Liu L; Jiao J; Wang Y; Zhang D; Wu J; Huang D
PLoS One; 2014; 9(3):e90931. PubMed ID: 24603722
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis.
Zheng Y; Li L; Shen H; Sturgis EM; Eicher SA; Strom SS; Spitz MR; Wei Q
Carcinogenesis; 2001 Dec; 22(12):2005-8. PubMed ID: 11751432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
